These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 17728005

  • 1. Overexpression of matrix metalloproteinase-7 (MMP-7) correlates with tumor proliferation, and a poor prognosis in non-small cell lung cancer.
    Liu D, Nakano J, Ishikawa S, Yokomise H, Ueno M, Kadota K, Urushihara M, Huang CL.
    Lung Cancer; 2007 Dec; 58(3):384-91. PubMed ID: 17728005
    [Abstract] [Full Text] [Related]

  • 2. Wnt1 overexpression associated with tumor proliferation and a poor prognosis in non-small cell lung cancer patients.
    Nakashima T, Liu D, Nakano J, Ishikawa S, Yokomise H, Ueno M, Kadota K, Huang CL.
    Oncol Rep; 2008 Jan; 19(1):203-9. PubMed ID: 18097596
    [Abstract] [Full Text] [Related]

  • 3. Wnt1 overexpression promotes tumour progression in non-small cell lung cancer.
    Huang CL, Liu D, Ishikawa S, Nakashima T, Nakashima N, Yokomise H, Kadota K, Ueno M.
    Eur J Cancer; 2008 Nov; 44(17):2680-8. PubMed ID: 18790633
    [Abstract] [Full Text] [Related]

  • 4. E2F1 overexpression correlates with thymidylate synthase and survivin gene expressions and tumor proliferation in non small-cell lung cancer.
    Huang CL, Liu D, Nakano J, Yokomise H, Ueno M, Kadota K, Wada H.
    Clin Cancer Res; 2007 Dec 01; 13(23):6938-46. PubMed ID: 18056168
    [Abstract] [Full Text] [Related]

  • 5. Matrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable non-small cell lung cancer.
    Cox G, Jones JL, O'Byrne KJ.
    Clin Cancer Res; 2000 Jun 01; 6(6):2349-55. PubMed ID: 10873086
    [Abstract] [Full Text] [Related]

  • 6. Expression of vascular endothelial growth factor-A and vascular endothelial growth factor-C as prognostic factors for non-small cell lung cancer.
    Nakashima T, Huang CL, Liu D, Kameyama K, Masuya D, Ueno M, Haba R, Yokomise H.
    Med Sci Monit; 2004 Jun 01; 10(6):BR157-65. PubMed ID: 15173661
    [Abstract] [Full Text] [Related]

  • 7. Wnt3 gene expression promotes tumor progression in non-small cell lung cancer.
    Nakashima N, Liu D, Huang CL, Ueno M, Zhang X, Yokomise H.
    Lung Cancer; 2012 May 01; 76(2):228-34. PubMed ID: 22070884
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Matrix metalloproteinase-13 expression is associated with bone marrow microinvolvement and prognosis in non-small cell lung cancer.
    Hsu CP, Shen GH, Ko JL.
    Lung Cancer; 2006 Jun 01; 52(3):349-57. PubMed ID: 16569461
    [Abstract] [Full Text] [Related]

  • 10. Expression and clinical significance of matrix metalloproteinase (MMP)-26 protein in non-small cell lung cancer.
    Li L, Mei TH, Zhou XD, Zhang XG.
    Ai Zheng; 2009 Jan 01; 28(1):60-3. PubMed ID: 19448419
    [Abstract] [Full Text] [Related]

  • 11. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH, Wang SF, Yu L, Wang J, Chang H, Yan WL, Zhang J, Fu K.
    Lung Cancer; 2008 Oct 01; 62(1):113-9. PubMed ID: 18550205
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Relationship between expression of matrix metalloproteinase (MMP-9) and tumor angiogenesis, cancer cell proliferation, invasion, and metastasis in invasive carcinoma of cervix].
    Jiang ZQ, Zhu FC, Qu JY, Zheng X, You CL.
    Ai Zheng; 2003 Feb 01; 22(2):178-84. PubMed ID: 12600296
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Combined analysis of cyclooxygenase-2 expression with p53 and Ki-67 in nonsmall cell lung cancer.
    Tsubochi H, Sato N, Hiyama M, Kaimori M, Endo S, Sohara Y, Imai T.
    Ann Thorac Surg; 2006 Oct 01; 82(4):1198-204. PubMed ID: 16996907
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Expression of tissue inhibitor of metalloproteinase-3 (TIMP-3) and its prognostic significance in resected non-small cell lung cancer.
    Mino N, Takenaka K, Sonobe M, Miyahara R, Yanagihara K, Otake Y, Wada H, Tanaka F.
    J Surg Oncol; 2007 Mar 01; 95(3):250-7. PubMed ID: 17323339
    [Abstract] [Full Text] [Related]

  • 18. Influence of angiogenetic factors and matrix metalloproteinases upon tumour progression in non-small-cell lung cancer.
    Shou Y, Hirano T, Gong Y, Kato Y, Yoshida K, Ohira T, Ikeda N, Konaka C, Ebihara Y, Zhao F, Kato H.
    Br J Cancer; 2001 Nov 30; 85(11):1706-12. PubMed ID: 11742492
    [Abstract] [Full Text] [Related]

  • 19. WWOX expression in different histologic types and subtypes of non-small cell lung cancer.
    Donati V, Fontanini G, Dell'Omodarme M, Prati MC, Nuti S, Lucchi M, Mussi A, Fabbri M, Basolo F, Croce CM, Aqeilan RI.
    Clin Cancer Res; 2007 Feb 01; 13(3):884-91. PubMed ID: 17289881
    [Abstract] [Full Text] [Related]

  • 20. Overexpression of matrix metalloproteinase 2 predicts unfavorable outcome in early-stage non-small cell lung cancer.
    Passlick B, Sienel W, Seen-Hibler R, Wöckel W, Thetter O, Mutschler W, Pantel K.
    Clin Cancer Res; 2000 Oct 01; 6(10):3944-8. PubMed ID: 11051242
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.